Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Synaptics (Nasdaq: SYNA) and Murata Partner to Develop Automotive Wireless Connectivity Module

Synaptics® Incorporated (Nasdaq: SYNA) and Murata Manufacturing have announced a collaboration to create a next-generation turnkey wireless connectivity module aimed at automotive Tier 1 suppliers and original equipment manufacturers (OEMs). The module will incorporate Synaptics' Veros™ Wi-Fi and Bluetooth combo systems on chips (SoCs), …

Team Kalkine | 01 May 2025

Compañia de Minas Buenaventura S.A.A. (NYSE: BVN; BUE.LM) Reports First Quarter 2025 Financial and Operational Results

Compañia de Minas Buenaventura S.A.A. (NYSE: BVN; BUE.LM), a Peru-based precious metals mining company, reported its financial and operational results for the first quarter of 2025. The company recorded EBITDA of US$126.3 million from direct operations, up from US$94.5 million in the same quarter …

Team Kalkine | 01 May 2025

XPeng Inc. (NYSE: XPEV, HKEX: 9868) Reports April 2025 Deliveries and Technology Service Launch

XPeng Inc. (NYSE: XPEV, HKEX: 9868) announced vehicle delivery results for April 2025, reporting a total of 35,045 Smart EVs delivered. This figure represents a 273% increase compared to April 2024 and marks the sixth consecutive month the company has surpassed the 30,000-unit threshold. …

Team Kalkine | 01 May 2025

Zeekr Group (NYSE: ZK) Reports April 2025 Deliveries and Model Launch Updates

ZEEKR Intelligent Technology Holding Limited (NYSE: ZK) reported delivery results for April 2025, with a total of 41,316 vehicles delivered across its Zeekr and Lynk & Co brands. This marks a 1.5% increase compared to March 2025. The Zeekr brand accounted for 13,727 of …

Team Kalkine | 01 May 2025

BriaCell Therapeutics Corp. (TSX: BCT) Presents Phase 3 Data on Biomarker-Driven Approach in Metastatic Breast Cancer

BriaCell Therapeutics Corp., a clinical-stage biotechnology company, has presented new data from its ongoing pivotal Phase 3 trial of Bria-IMT™, an investigational immunotherapy for metastatic breast cancer (MBC). The study, titled BRIA-ABC (NCT06072612), explores how specific biomarkers might predict patient response to the Bria-IMT …

Team Kalkine | 30 April 2025

Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) Signs Landmark B2B Pre-Order Deal for 1,000 FX Super One MPVs

Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) has signed its first binding B2B pre-order agreement for its FX Super One MPV, marking a significant commercial development. The agreement, involving New York City dealership 129 Auto Sales Corp. (operating as JC Auto), includes a $100,000 …

Team Kalkine | 30 April 2025

Basel Medical Group Ltd (Nasdaq: BMGL) Finalizes Acquisition of Bethesda Medical to Expand Southeast Asia Presence

Basel Medical Group Ltd (Nasdaq: BMGL) has completed the acquisition of Bethesda Medical Pte. Ltd., a Singapore-based healthcare provider with three decades of experience in diagnostic imaging and outpatient medical services. The move strengthens Basel Medical’s footprint in Singapore and initiates its broader strategy …

Team Kalkine | 30 April 2025